NASDAQ:STAA - STAAR Surgical Stock Price, Price Target & More

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

STAAR Surgical (NASDAQ:STAA) announced its quarterly earnings results on Wednesday, May, 2nd. The medical instruments supplier reported $0.04 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.08. The medical instruments supplier earned $27.09 million during the quarter, compared to analysts' expectations of $23 million. STAAR Surgical had a net margin of 0.66% and a return on equity of 6.80%. During the same quarter in the prior year, the company earned ($0.05) EPS. View STAAR Surgical's Earnings History.

STAAR Surgical is scheduled to release their next quarterly earnings announcement on Wednesday, August, 1st 2018. View Earnings Estimates for STAAR Surgical.

4 analysts have issued twelve-month price targets for STAAR Surgical's shares. Their forecasts range from $21.00 to $32.00. On average, they anticipate STAAR Surgical's stock price to reach $24.6667 in the next twelve months. View Analyst Ratings for STAAR Surgical.

STAAR Surgical saw a drop in short interest in May. As of May 15th, there was short interest totalling 494,547 shares, a drop of 49.1% from the April 30th total of 971,594 shares. Based on an average daily trading volume, of 872,862 shares, the days-to-cover ratio is presently 0.6 days. Currently, 1.2% of the shares of the stock are short sold. View STAAR Surgical's Current Options Chain.

Some companies that are related to STAAR Surgical include Masimo (MASI), GALAPAGOS NV/S (GLPG), GN Store Nord A/S (GGNDF), Penumbra (PEN), United Therapeutics (UTHR), Chemed (CHE), Foundation Medicine (FMI), LivaNova (LIVN), Healthequity (HQY), Syneos Health (SYNH), ELEKTA AB/ADR (EKTAY), Medidata Solutions (MDSO), Haemonetics (HAE), Premier (PINC) and Taro Pharmaceutical Industries (TARO).

Media stories about STAA stock have trended positive on Monday, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. STAAR Surgical earned a daily sentiment score of 0.36 on Accern's scale. They also gave media stories about the medical instruments supplier an impact score of 45.50 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

STAAR Surgical's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Palo Alto Investors LP (8.45%), BlackRock Inc. (6.53%), Baillie Gifford & Co. (2.58%), Cortina Asset Management LLC (0.95%), Millennium Management LLC (0.79%) and Principal Financial Group Inc. (0.50%). Company insiders that own STAAR Surgical stock include Broadwood Partners Lp, Caren L Mason, Deborah J Andrews, Hans-Martin Blickensdoerfer, Keith Holliday and Samuel J Gesten. View Institutional Ownership Trends for STAAR Surgical.

STAA stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Cortina Asset Management LLC, Lincoln National Corp, A.R.T. Advisors LLC, Principal Financial Group Inc., Principal Financial Group Inc., Barclays PLC and Public Employees Retirement Association of Colorado. Company insiders that have sold STAAR Surgical company stock in the last year include Caren L Mason, Deborah J Andrews, Keith Holliday and Samuel J Gesten. View Insider Buying and Selling for STAAR Surgical.

STAA stock was bought by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., King Luther Capital Management Corp, Next Century Growth Investors LLC, BlackRock Inc., Millrace Asset Group Inc., Palo Alto Investors LP, Element Capital Management LLC and GSA Capital Partners LLP. View Insider Buying and Selling for STAAR Surgical.

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of STAA stock can currently be purchased for approximately $30.40.

STAAR Surgical has a market capitalization of $1.30 billion and generates $90.61 million in revenue each year. The medical instruments supplier earns $-2,130,000.00 in net income (profit) each year or $0.01 on an earnings per share basis. STAAR Surgical employs 353 workers across the globe.

STAAR Surgical's mailing address is 1911 WALKER AVENUE, MONROVIA CA, 91016. The medical instruments supplier can be reached via phone at 626-303-7902 or via email at [email protected]